Pascal Deschatelets Apellis Pharmaceuticals, Inc. (APLS) insider trading activity

Pascal Deschatelets is Chief Scientific Officer of Apellis Pharmaceuticals, Inc.. Currently has a direct ownership of 1.16 Million shares of APLS, which is worth approximately $24.1 Million. The most recent transaction as insider was on May 21, 2025, when has been sold 12,780 shares (Common Stock) at a price of $3.76 per share, resulting in proceeds of $48,052. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 1.16M

0% 3M change

1.75% 12M change

Total Value Held $24.1 Million

Pascal Deschatelets Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
May 21 2025	BUY Exercise of conversion of derivative security	$48,052 $3.76 p/Share	12,780 Added 1.09%	1,160,496 Common Stock
Jan 29 2025	SELL Open market or private sale	$24,383 $29.52 p/Share	826 Reduced 0.07%	1,147,716 Common Stock
Jan 22 2025	SELL Open market or private sale	$120,137 $30.43 p/Share	3,948 Reduced 0.34%	1,148,542 Common Stock
Jan 21 2025	BUY Grant, award, or other acquisition	-	15,045 Added 1.29%	1,152,490 Common Stock
Jan 17 2025	SELL Open market or private sale	$22,470 $29.96 p/Share	750 Reduced 0.07%	1,137,445 Common Stock
Jan 13 2025	SELL Open market or private sale	$65,665 $28.7 p/Share	2,288 Reduced 0.2%	1,138,195 Common Stock
May 20 2024	BUY Exercise of conversion of derivative security	$92,120 $3.76 p/Share	24,500 Added 2.1%	1,140,483 Common Stock
May 08 2024	SELL Open market or private sale	$3,393,790 $43.01 p/Share	78,907 Reduced 6.6%	1,115,983 Common Stock
May 08 2024	BUY Exercise of conversion of derivative security	$340,089 $4.31 p/Share	78,907 Added 6.19%	1,194,890 Common Stock
Apr 08 2024	SELL Open market or private sale	$3,767,713 $54.52 p/Share	69,107 Reduced 5.83%	1,115,983 Common Stock
Apr 08 2024	BUY Exercise of conversion of derivative security	$259,842 $3.76 p/Share	69,107 Added 5.51%	1,185,090 Common Stock
Mar 08 2024	SELL Open market or private sale	$4,328,862 $62.64 p/Share	69,107 Reduced 5.83%	1,115,983 Common Stock
Mar 08 2024	BUY Exercise of conversion of derivative security	$253,622 $3.67 p/Share	69,107 Added 5.51%	1,185,090 Common Stock
Feb 12 2024	SELL Open market or private sale	$77,799 $67.77 p/Share	1,148 Reduced 0.1%	1,115,983 Common Stock
Jan 29 2024	SELL Open market or private sale	$56,058 $64.14 p/Share	874 Reduced 0.08%	1,117,131 Common Stock
Jan 22 2024	SELL Open market or private sale	$254,345 $65.0 p/Share	3,913 Reduced 0.35%	1,118,005 Common Stock
Jan 16 2024	SELL Open market or private sale	$109,033 $66.81 p/Share	1,632 Reduced 0.15%	1,121,918 Common Stock
Jan 16 2024	BUY Grant, award, or other acquisition	-	6,743 Added 0.6%	1,123,550 Common Stock
Nov 14 2023	BUY Exercise of conversion of derivative security	$169,200 $3.76 p/Share	45,000 Added 3.87%	1,116,807 Common Stock
Nov 08 2023	SELL Open market or private sale	$567,240 $47.27 p/Share	12,000 Reduced 1.11%	1,071,807 Common Stock
Nov 08 2023	BUY Exercise of conversion of derivative security	$46,708 $2.67 p/Share	17,494 Added 1.59%	1,083,807 Common Stock
Oct 09 2023	SELL Open market or private sale	$484,560 $40.38 p/Share	12,000 Reduced 1.11%	1,066,313 Common Stock
Oct 09 2023	BUY Exercise of conversion of derivative security	$49,395 $2.67 p/Share	18,500 Added 1.69%	1,078,313 Common Stock
Sep 08 2023	SELL Open market or private sale	$514,439 $42.87 p/Share	12,000 Reduced 1.12%	1,059,813 Common Stock
Sep 08 2023	BUY Exercise of conversion of derivative security	$49,395 $2.67 p/Share	18,500 Added 1.7%	1,071,813 Common Stock

Pascal Deschatelets

Chief Scientific Officer

Waltham, MA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells APLS shares.

Notify only if

Value

Insider Trading

Get notified when an Apellis Pharmaceuticals, Inc. insider buys or sells APLS shares.

Notify only if

Operation

Value

Type

News

Receive news related to Apellis Pharmaceuticals, Inc.

Track Activities on APLS

Account